/** * @license * MyFonts Webfont Build ID 484582 * * The fonts listed in this notice are subject to the End User License * Agreement(s) entered into by the website owner. All other parties are * explicitly restricted from using the Licensed Webfonts(s). * * You may obtain a valid license from one of MyFonts official sites. * http://www.fonts.com * http://www.myfonts.com * http://www.linotype.com * */
21 feb 2022

HealthInvest Partners becomes a part of Atle


Atle Investment Management AB (“Atle”) has entered into an agreement to acquire 51% of the shares in HealthInvest Partners AB (“HealthInvest”) from the current owners. Healthinvest will thus become part of Atle together with TIN Fonder, Alcur Fonder, Fondita and Humle Fonder.

“We are very pleased to have the opportunity to build on HealthInvest’s fine brand and track record. Healthcare is a very interesting theme with strong underlying growth drivers, but it is a complex industry to navigate that is well suited for specialized investment teams.” says Gustav Ohlsson, CEO of Atle.

HealthInvest was founded in 2006 by Anders Hallberg and Carl Bennet as an independent fund company specializing in the healthcare sector. The fund company manages HealthInvest Alpha Fund with approximately SEK 1.3 billion in fund assets. The fund is actively managed and invests globally in healthcare companies. The management strategy is value-based and primarily focused on profit-generating companies in which the manager perceives the potential for a sharp revaluation.

Atle’s ambition, along with current owners, is to further enhance the business and make HealthInvest’s fund available to more investors.

“Atle has succeeded incredibly well in its previous investments, and we are proud to be part of its fund operations. HealthInvest has a strong track record and has delivered the highest risk-adjusted excess return in relation to other funds in this category. Hopefully we can contribute to Atle becoming an even stronger unit.” says Anders Hallberg, portfolio manager and co-founder HealthInvest.

The completion of the acquisition is subject to customary regulatory approvals by the Swedish Financial Supervisory Authority, which are expected to be received in May 2022.

For more information about HealthInvest Partners, visit www.healthinvest.se.